🇮🇳·10h agoIndustry
natco receives approval from central drug standard control organisation cdsco for semaglutide in india
Publisher
N
Natco Pharma
India
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on natcopharma.co.in
Leave the platform to read the original full article on the publisher site.
Source: Natco Pharma
Scope: Industry
Related coverage
More related coverage
Roche Newsroom·5h ago
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
Ipsen·5h ago
The role of biomarkers: how new modalities are making precision medicine a reality
Ipsen RSS·5h ago
The role of biomarkers: how new modalities are making precision medicine a reality
Natco Pharma·10h ago